EarlySight is a Swiss startup company focused on reducing vision-loss by enabling earlier detection and better monitoring of eye degenerative diseases.
The company was founded in March 2019 as a spinoff of the Swiss Federal Institute of Technology in Lausanne (EPFL). It uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.
The eye imaging device in development observes the cells affected at early-stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma, or diabetic retinopathy, with the expected goal to enable earlier diagnoses and more efficient treatments.
The company was founded in March 2019 as a spinoff of the Swiss Federal Institute of Technology in Lausanne (EPFL). It uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.
The eye imaging device in development observes the cells affected at early-stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma, or diabetic retinopathy, with the expected goal to enable earlier diagnoses and more efficient treatments.
Key information
- Medical technology
- Avenue de Sécheron 15, 1202 Genève
- EarlySight SA
New jobs directly in your mailbox?
Currently, there are no job offers. Follow this company, and we’ll inform you by email as soon as new jobs become available.